ライフサイエンスコーパス: dual X-ray absorptiometry

1 nts (femoral neck and/or lumbar spine) using dual x-ray absorptiometry.

2 aphy, and body composition was quantified by dual x-ray absorptiometry.

3 BMD was measured at baseline and annually by dual x-ray absorptiometry.

4 indirect calorimetry and body composition by dual x-ray absorptiometry.

5 l as with BMD of the lumbar spine and hip at dual x-ray absorptiometry.

6 ity, and body composition were determined by dual x-ray absorptiometry.

7 ans ordering bone mineral density tests with dual x-ray absorptiometry.

8 D measurements of the hip were obtained with dual x-ray absorptiometry.

9 e., muscle) mass in the lower extremities by dual x-ray absorptiometry.

10 ALM was assessed by dual X-ray absorptiometry.

11 Dual X-ray absorptiometry already has an established rol

12 Lean mass was estimated by dual X-ray absorptiometry and examined as leg lean mass

13 Bone quality was analyzed using peripheral dual x-ray absorptiometry and micro-computed tomography.

14 Percent body fat (BF) was assessed via dual X-ray absorptiometry and PA was determined via a mu

15 eck were obtained through 1998-1999 by using dual x-ray absorptiometry and were standardized (as z sc

16 (bone mineral density [BMD], by quantitative dual x-ray absorptiometry) and morphologic appraisals of

17 one mineral density (BMD) was measured using dual x-ray absorptiometry, and fractures were determined

18 flammation, bone mineral density (BMD) using dual x-ray absorptiometry, and magnetic resonance imagin

19 Dual x-ray absorptiometry-assessed body composition (inc

20 Neonatal body composition was assessed by dual X-ray absorptiometry at age 2 weeks.

21 Hip bone mineral density was measured with dual x-ray absorptiometry at baseline and again an avera

22 Total body BMD (TBBMD) was measured by dual x-ray absorptiometry at baseline and every 6 months

23 Patients underwent dual x-ray absorptiometry at the hip and spine and hand

24 BMD was measured by dual x-ray absorptiometry at the left hip, lumbar spine,

25 Dual X-ray absorptiometry (DEXA) was used to determine b

26 Lumbar spine dual X-ray absorptiometry does not consistently distingu

27 recruits, and bone mineral density (BMD) by Dual X-Ray Absorptiometry (DXA) and repeated after 12 we

28 isits 1 and 5 (mean 8.3 years apart) and hip dual x-ray absorptiometry (DXA) had been performed (2 ye

29 European descent underwent >=2 per-protocol dual x-ray absorptiometry (DXA) measurements >=2 years a

30 The 1/T2* MR imaging relaxation rates and dual X-ray absorptiometry (DXA) measurements were evalua

31 (median, 7.7 years) using anthropometric and dual X-ray absorptiometry (DXA) measurements.

32 ockout (A(1)R-knockout) mice was analyzed by dual x-ray absorptiometry (DXA) scanning, and the trabec

33 th Initiative (WHI) with repeated whole body Dual X-Ray Absorptiometry (DXA) scans with derived abdom

34 ndheld bioimpedance (BIA) device relative to dual X-ray absorptiometry (DXA) to assess body compositi

35 Dual x-ray absorptiometry (DXA) was performed before tre

36 Dual x-ray absorptiometry (DXA) was used to quantify bre

37 Weight, height and breast composition by dual X-ray absorptiometry (DXA) were measured in daughte

38 neral bone characteristics as measured using dual x-ray absorptiometry (DXA), and to assess their rel

39 the lumbar spine or hip, as demonstrated by dual x-ray absorptiometry (DXA), and were receiving long

40 whether predictions were based on body mass, dual x-ray absorptiometry (DXA)-derived body composition

41 ekly and body composition was measured using dual x-ray absorptiometry (DXA).

42 MR imaging, anthropometric measurement, and dual x-ray absorptiometry (DXA).

43 g bioelectrical impedance analysis (BIA) and dual x-ray absorptiometry (DXA); and central adiposity,

44 Clinical and bone densitometry (dual x-ray absorptiometry [DXA]) records were reviewed i

45 Bone densities (dual x-ray absorptiometry [DXA]) were normal, low, or os

46 s in skeletal muscle mass, as represented by dual X-ray absorptiometry fat free mass and ALM, over th

47 it analyses of dynamic knee loads as well as dual x-ray absorptiometry for determination of bone mine

48 Dual X-ray absorptiometry imaging was repeated at 3 and

49 nalysis, mean (SD) whole-body BMD z score by dual x-ray absorptiometry improved by 0.25 (0.78) in the

50 at and skeletal muscle mass using whole-body dual X-ray absorptiometry in 142 adult lung transplant c

51 BMC and BMD were measured by dual x-ray absorptiometry in 41 children with JRA and 62

52 tandard assessments of body composition (via dual X-ray absorptiometry), insulin sensitivity (via hyp

53 Dual x-ray absorptiometry is currently the state-of-the-

54 ded the primary outcome (VO(2peak)); MRI and dual X-ray absorptiometry; leg muscle strength and quali

55 al adiponectin ratio (HMWr), 24-hr ABPM, and dual x-ray absorptiometry measures of fat mass were obta

56 rieved from implant sites were assessed with dual x-ray absorptiometry, microcomputed tomography, and

57 is was performed for patients evaluated with dual x-ray absorptiometry (n = 2106).

58 volumetric quantitative CT of L1 and L2 and dual x-ray absorptiometry of the hip.

59 nge of imaging features from radiographs and dual x-ray absorptiometry of the knee.

60 Body composition was measured annually by dual X-ray absorptiometry, physical activity by accelero

61 with BMD (total and subregions) measured by dual x-ray absorptiometry scans and complete information

62 For the subset with dual x-ray absorptiometry T-scores, 2-year AUC was 0.74

63 body potassium (TBK) as a measure of BCM and dual x-ray absorptiometry to determine fat mass.

64 easure the carotid plaque index and IMT, and dual x-ray absorptiometry to measure BMD at the lumbar s

65 Participants underwent whole-body dual X-ray absorptiometry to measure fat free mass, appe

66 uantitate changes in thigh muscle volume and dual x-ray absorptiometry was used to quantitate changes